Kala Pharmaceuticals Inc (KALA) — Defensive Interval Ratio

Latest as of September 2025: 0 days

Kala Pharmaceuticals Inc (KALA) has a Defensive Interval Ratio of 0 days as of September 2025. Defensive assets of $8.00K (cash $-, short-term investments $-, receivables $8.00K) cover 0 days of daily cash needs of $89.24K/day.

Defensive Interval Ratio

0 days
Days of operational coverage

Defensive Assets

$8.00K
Cash + ST Investments + Receivables

Daily Cash Need

$89.24K
Current Liabilities ÷ 365

Current Liabilities

$32.57 Million
USD

Kala Pharmaceuticals Inc Defensive Interval Ratio (2013–2023)

This chart shows how Kala Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 9 annual periods from 2013 to 2023. As of September 2025, the ratio stands at 0 days, meaning defensive assets of $8.00K can fund 0 days of operations without new revenue. For the complete balance sheet picture, see KALA current and non-current assets.

Annual Defensive Interval Ratio for Kala Pharmaceuticals Inc (2013–2023)

The table below presents the year-by-year Defensive Interval Ratio for Kala Pharmaceuticals Inc from 2013 to 2023, covering 9 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Kala Pharmaceuticals Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2023 10 days $236.00K $22.87K/day $- $- ▼ -82 days
2022 92 days $6.50 Million $70.37K/day $- $- ▼ -78 days
2021 170 days $17.45 Million $102.53K/day $- $0.00 ▼ -1244 days
2020 1415 days $86.13 Million $60.89K/day $- $76.28 Million ▲ +1211 days
2019 203 days $13.80 Million $67.87K/day $- $699.00K ▲ +181 days
2018 22 days $1.03 Million $46.60K/day $- $- ▲ +22 days
2017 0 days $0.00 $39.61K/day $- $0.00 ▼ -5 days
2014 5 days $38.00K $8.09K/day $- $- ▼ -15 days
2013 20 days $303.00K $15.30K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)